A kind of iridium complex and its synthesis method and application

A synthesis method and compound technology, applied in the field of medicine, can solve the problem of low toxicity of liver cells, and achieve the effect of significant biological activity

Active Publication Date: 2021-06-01
西藏贝斯特药业有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, 8-hydroxyquinoline is used as a pharmaceutical intermediate, but it has not been seen that 5-chloro-8-hydroxyquinoline and 7,8-benzoquinoline iridium dimer are used as ligands to make the obtained iridium complex Reports that the drug has significant biological activity on tumor cells and has low toxicity to normal human liver cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of iridium complex and its synthesis method and application
  • A kind of iridium complex and its synthesis method and application
  • A kind of iridium complex and its synthesis method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] In a 100.0mL round bottom flask, add 2.0mmol of 5-chloro-8-hydroxyquinoline and 1.0mmol of 7,8-benzoquinoline iridium dimer, and then add 15.5mL of organic solvent (from 15.0mL of ethanol and 0.5mL of dimethyl sulfoxide), stirred to dissolve, reacted at 55°C until complete (about 8h), stopped the reaction, cooled to room temperature, reddish-brown crystals were precipitated, collected and dried to obtain reddish-brown solid product. Yield 79.99%.

[0021] The product obtained in this embodiment is characterized:

[0022] (1) X-ray single crystal diffraction

[0023] The reddish-brown crystal with perfect surface structure was measured by single crystal diffraction to determine its crystal structure. The obtained crystallographic and structural correction data are shown in Table 1 below, and the data of some bond lengths and angles are shown in Table 2 and Table 3 below. The crystal structure of reddish-brown crystals is as figure 1 shown.

[0024] Table 1. Crystall...

Embodiment 2

[0042] Example 1 was repeated, except that the organic solvent was changed to consist of 1.0 mL of ethanol and 15 mL of dichloromethane, and the reaction was carried out at 35° C. (about 50 h to complete the reaction).

[0043] The result is reddish-brown crystals. Yield 91.24%.

[0044] Single crystal diffraction analysis, elemental analysis, infrared analysis and mass spectrometry analysis were performed on the product obtained in this example, and the obtained reddish-brown crystal was determined to be the target compound.

Embodiment 3

[0046] Example 1 was repeated, except that the organic solvent was changed to consist of 3.0 mL of ethanol, 5.0 mL of water and 12.0 mL of acetone, and the reaction was carried out at 80° C. (about 35 h to complete the reaction).

[0047] The result is reddish-brown crystals. Yield 80.55%.

[0048]Single crystal diffraction analysis, elemental analysis, infrared analysis and mass spectrometry analysis were performed on the product obtained in this example, and the obtained reddish-brown crystal was determined to be the target compound.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an iridium complex and its synthesis method and application. The synthesis method of the complex is: taking 5-chloro-8-hydroxyquinoline and 7,8-benzoquinoline iridium dimer in an organic In a solvent, react under heating or without heating to obtain the target compound; wherein, the organic solvent is ethanol, or ethanol mixed with water, acetone, dichloromethane, chloroform, dimethyl sulfoxide and One or a combination of two or more of N,N-dimethylformamides. The applicant's test results show that the complex has significant biological activity (activity significantly higher than cisplatin) to cervical cancer and ovarian cancer cells, and it has minimal toxicity to normal human liver cells (IC 50 >80μM).

Description

technical field [0001] The invention relates to an iridium complex and its synthesis method and application, belonging to the technical field of medicine. Background technique [0002] Cancer is one of the most serious malignant diseases threatening human life and health. At present, more than three million people die of cancer every year in our country, which has seriously threatened the life and health of our people. Platinum complexes such as cisplatin are currently one of the most widely used chemotherapeutic drugs and one of the first-choice drugs for the treatment of many cancers (Lippard, S.J.; et al. Chem. Sci., 2015, 6, 1189–1193.). However, the extensive use of platinum-based drugs such as cisplatin in clinical practice can easily lead to drug resistance and severe side effects such as nephrotoxicity, neurotoxicity and bone marrow suppression, which greatly limit their therapeutic effect and long-term use (Lippard, S.J.; et al. al. Chem. Sci., 2015, 6, 1189–1193....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07F15/00A61K31/555A61P35/00
CPCA61P35/00C07F15/0033
Inventor 邹华红蒙婷梁福沛
Owner 西藏贝斯特药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products